New concepts in insulin resistance of pregnancy and gestational diabetes: Long-term implications for mother and offspring

Journal of Obstetrics and Gynaecology

Volumn 23, Issue 5, 2003, Pages 545-549

  Barbour, Linda A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

AMINO ACID TRANSPORT; ANAMNESIS; CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; FETOPLACENTAL UNIT; GENETIC RISK; GLUCONEOGENESIS; HUMAN; INSULIN RESISTANCE; MACROSOMIA; MEDICAL RESEARCH; METABOLIC REGULATION; MOTHER FETUS RELATIONSHIP; NON INSULIN DEPENDENT DIABETES MELLITUS; PLACENTA DEVELOPMENT; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROGENY; PUERPERIUM;

DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; PLACENTAL HORMONES; PREGNANCY; RISK FACTORS;

EID: 0141504458     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/0144361031000156500     Document Type: Conference Paper

References (29)

1. Aldoretta P.W. and Hay W.W. (1995) Metabolic substrates for fetal energy metabolism and growth. Clinical Perinatology, 22, 15-35.
2. Alsat E., Guibourdenche J., Couturier A. and Evain-Brion D. (1998) Physiological role of human placental growth hormone. Molecular and Cellular Endocrinology, 140, 121-127.
3. Anthony R.V., Limesand S.W., Fanning M.D. and Liang R. (1998) Placental lactogen and growth hormone. In: Endocrinology of Pregnancy, edited by Bazer F.W., pp. 461-490. Totowa, New Jersey, Humana Press.
4. Barbour L.A. and Reusch J.E.-B. (2001) Diabetes in pregnancy. In: Endocrine Secrets, 3rd edn, edited by McDermott M., pp. 308-316. Philadelphia, Hanley & Belfus.
5. Barbour L.A., Shao J., Qiao L., Pulawa L.K., Jensen D.R., Bartke A., Garrity M., Draznin B. and Friedman J.E. (2002) Human placental growth hormone causes severe insulin resistance in transgenic mice. American Journal of Obstetrics and Gynecology, 186, 512-517.
6. Brelje T.C., Scharp D.W., Lacy P.E., Ogren L., Talamantes F., Robertson M., Friesen H.G. and Sorenson R.L. (1993) Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology, 132, 879-887.
7. Buchanan T.A., Kjos S.L., Montoro M.N., Wu P.Y., Madrilejo N.G., Gonzalez M., Nunez V., Pantoja P.M. and Xiang A. (1994) Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care, 17, 275-283.
8. Buchanan T.A., Xiang A.H., Peters R.K., Kjos. S.L., Marroquin A., Goico J., Ochoa C., Tan S., Berkowitz K., Hodis H.N. and Azen S.P. (2002) Preservation of pancreatic beta-cell function and prevention of Type 2 diabetes by pharmacolgical treatment of insulin resistance in high-risk Hispanic women. Diabetes, 51, 2796-2803.
9. Catalano P.M., Huston L., Amini S.B. and Kalhan S.C. (1999) Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. American Journal of Obstetrics and Gynecology, 180, 903-916.
10. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics and Division of Health Interview Statistics (2000) Data from the National Health Interview Survey. CDC.
11. Conway D.L. and Langer O. (1999) Effects of new criteria for Type 2 diabetes on the rate of postpartum glucose intolerance in women with gestational diabetes. American Journal of Obstetrics and Gynecology, 191, 610-614.
12. Dabelea D., Knowler W.C. and Pettitt D.J. (2000) Effect of diabetes in pregnancy on offspring: follow-up research in the Pima Indians. Journal of Maternal - Fetal Medicine, 9, 83-88.
13. Diabetes Prevention Program Research Group (2002) Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393-403.
14. Evain-Brion D., Alsat E., Igout A., Frankenne F. and Hennen G. (1994) Placental growth hormone variant: assay and clinical aspects. Acta Paediatrica Supplementum, 399, 49-51.
15. Friedman J.E., Ishizuka T., Shao J., Huston L., Highman T. and Catalano P. (1999) Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes, 48, 1807-1814.
16. Gaither K., Quraishi A.N. and Illsley N.P. (1999) Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter. Journal of Clinical Endocrinology and Metabolism, 84, 695-701.
17. Garvey W.T., Maianu L., Zhu J.H., Hancock J.A. and Golichowski A.M. (1993) Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Diabetes, 42, 1773-1785.
18. Haeusler M.C.H., Konstantiniuk P., Dorfer M. and Weiss P.A.M. (1998) Amniotic fluid insulin testing in gestational diabetes: safety and acceptance of amniocentesis. American Journal of Obstetrics and Gynecology, 179, 917-920.
19. Handwerger S. and Freemark M. (2000) The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. Journal of Pediatric Endocrinology and Metabolism, 13, 343-356.
20. Kaufmann R.C., Schleyhahn F.T., Huffman D.G. and Amankwah K.S. (1995) Gestational diabetes diagnostic criteria: long-term maternal follow-up. American Journal of Obstetrics and Gynecology, 172, 621-625.
21. Kirwan J.P., Hauguel-De Mouzon S., Lepercq J., Challier J.C., Huston-Presley L., Friedman J.E., Kalhan S.C. and Catalano P.M. (2002) TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes, 51, 2207-2213.
22. Kjos S.L., Peters R.J., Xiang A., Henry O.A., Montoro M. and Buchanan T. (1995) Predicting future diabetes in Latino women with gestational diabetes. Diabetes, 44, 586-591.
23. Kuhl C. (1998) Etiology and pathogenesis of gestational diabetes. Diabetes Care, 21, B19-B26.
24. Okuno S., Akazawa S., Yasuhi I., Kawasaki E., Matsumoto K., Yamasaki H., Matsuo H., Yamaguchi Y. and Nagataki S. (1995) Decreased expression of the GLUT4 glucose transporter protein in adipose tissue during pregnancy. Hormone and Metabolic Research, 27, 231-234.
25. Shao J., Catalano P.M., Yamashita H., Ruyter I., Smith S., Youngren J. and Friedman J.E. (2000) Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes (GDM). Diabetes, 610, 603-610.
26. Silverman B.L. and Metzger B.E. (1995) Impaired glucose tolerance in adolescent offspring of diabetic mothers. Diabetes Care, 18, 611-617.
27. Weiss P.A.M., Scholz H.S., Haas J.H. and Tamussino K.F. (2001) Effect of fetal hyperinsulinemia on oral glucose tolerance test results in patients with gestational diabetes mellitus. American Journal of Obstetrics and Gynecology, 184, 470-475.
28. Yamashita H., Shao J. and Friedman J.E. (2000) Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes. Clinical Obstetrics and Gynecology, 43, 87-98.
29. Zumkeller W. (2000) The role of growth hormone and insulin-like growth factors for placental growth and development. Placenta, 21, 451-467.